These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17535170)

  • 1. Review of intermittent preventive treatment for malaria in infants and children.
    Munday S
    J Paediatr Child Health; 2007 Jun; 43(6):424-8. PubMed ID: 17535170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review: Intermittent preventive treatment--a new approach to the prevention of malaria in children in areas with seasonal malaria transmission.
    Greenwood B
    Trop Med Int Health; 2006 Jul; 11(7):983-91. PubMed ID: 16827699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent preventive treatment of malaria in infants: how does it work and where will it work?
    Gosling RD; Carneiro I; Chandramohan D
    Trop Med Int Health; 2009 Sep; 14(9):1003-10. PubMed ID: 19558374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IPTi Consortium: research for policy and action.
    Schellenberg D; Cisse B; Menendez C
    Trends Parasitol; 2006 Jul; 22(7):296-300. PubMed ID: 16713739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The promise and potential challenges of intermittent preventive treatment for malaria in infants (IPTi).
    O'Meara WP; Breman JG; McKenzie FE
    Malar J; 2005 Jul; 4():33. PubMed ID: 16033653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment for malaria in Mozambican infants.
    Mayor A; Serra-Casas E; Sanz S; Aponte JJ; Macete E; Mandomando I; Puyol L; Berzosa P; Dobaño C; Aide P; Sacarlal J; Benito A; Alonso P; Menéndez C
    J Infect Dis; 2008 Jun; 197(12):1737-42. PubMed ID: 18419347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The acceptability of intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in southern Tanzania.
    Pool R; Mushi A; Schellenberg JA; Mrisho M; Alonso P; Montgomery C; Tanner M; Mshinda H; Schellenberg D
    Malar J; 2008 Oct; 7():213. PubMed ID: 18939971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants.
    Kobbe R; Kreuzberg C; Adjei S; Thompson B; Langefeld I; Thompson PA; Abruquah HH; Kreuels B; Ayim M; Busch W; Marks F; Amoah K; Opoku E; Meyer CG; Adjei O; May J
    Clin Infect Dis; 2007 Jul; 45(1):16-25. PubMed ID: 17554695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of anti-malarial drugs to prevent malaria in the population of malaria-endemic areas.
    Greenwood B
    Am J Trop Med Hyg; 2004 Jan; 70(1):1-7. PubMed ID: 14971690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent preventive therapy for malaria: progress and future directions.
    Grobusch MP; Egan A; Gosling RD; Newman RD
    Curr Opin Infect Dis; 2007 Dec; 20(6):613-20. PubMed ID: 17975412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent preventive treatment for malaria and anaemia control in Tanzanian infants; the development and implementation of a public health strategy.
    Manzi F; Schellenberg J; Hamis Y; Mushi AK; Shirima K; Mwita A; Simba A; Rusibamayila N; Kitambi M; Tanner M; Alonso P; Mshinda H; Schellenberg D
    Trans R Soc Trop Med Hyg; 2009 Jan; 103(1):79-86. PubMed ID: 18823639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No rebound of morbidity following intermittent preventive sulfadoxine-pyrimethamine treatment of malaria in infants in Gabon.
    Grobusch MP; Gabor JJ; Aponte JJ; Schwarz NG; Poetschke M; Doernemann J; Schuster K; Koester KB; Profanter K; Borchert LB; Kurth F; Pongratz P; Issifou S; Lell B; Kremsner PG
    J Infect Dis; 2009 Dec; 200(11):1658-61. PubMed ID: 19848610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malaria prophylaxis and treatment: problems, recent developments and perspectives].
    Pradines B; Vial H; Olliaro P
    Med Trop (Mars); 2003; 63(1):79-98. PubMed ID: 12891756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malaria chemotherapeutics part I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development.
    Schlitzer M
    ChemMedChem; 2007 Jul; 2(7):944-86. PubMed ID: 17530725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of uncomplicated malaria in children: a review of treatment principles, essential drugs and current recommendations.
    Deen JL; von Seidlein L; Dondorp A
    Trop Med Int Health; 2008 Sep; 13(9):1111-30. PubMed ID: 18657092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent preventive treatment for malaria control in infants: moving towards evidence-based policy and public health action.
    Egan A; Crawley J; Schellenberg D;
    Trop Med Int Health; 2005 Sep; 10(9):815-7. PubMed ID: 16135186
    [No Abstract]   [Full Text] [Related]  

  • 17. Existing antimalarial agents and malaria-treatment strategies.
    D'Alessandro U
    Expert Opin Pharmacother; 2009 Jun; 10(8):1291-306. PubMed ID: 19463069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current antimalarial drugs recommended by the World Health Organization for the treatment and prevention of malaria].
    Baranova AM
    Med Parazitol (Mosk); 2007; (3):56-9. PubMed ID: 17912843
    [No Abstract]   [Full Text] [Related]  

  • 19. Malaria intermittent preventive treatment in infants, chemoprophylaxis, and childhood vaccinations.
    Rosen JB; Breman JG
    Lancet; 2004 Apr; 363(9418):1386-8. PubMed ID: 15110499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent preventive antimalarial treatment in infants.
    Greenwood B
    Clin Infect Dis; 2007 Jul; 45(1):26-8. PubMed ID: 17554696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.